Loading...

Echosens Webinar on Alcoholic Liver Diseases (ALD)

1,724 views

Loading...

Loading...

Transcript

The interactive transcript could not be loaded.

Loading...

Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on May 17, 2016

Clinical usefulness of FibroScan® and FibroMeter™
in alcoholic liver disease (ALD)
Speakers: Pr. Sebastian MUELLER & Pr. Ramon BATALLER
Contact: webinar@echosens.com
Program:
1- Introduction and clinical context
2- Description of markers available
3- Clinical Utility of FibroScan® and FibroMeter in alcoholic patients
-Evaluation of liver damage (fibrosis)
-Evaluation of steatosis with CAP (Controlled Attenuation Parameter)
4- Conclusion and perspectives
5- Discussion on Clinical cases
6- Interactive Questions/Answers session with participants

Legal Mentions:
ECHOSENS_WEBINAR_REPLAY2016- Revision date 05/18/2016 - FibroScan® is a medical device manufactured by Echosens. FibroScan is a CE marked Medical Device within the scope of the Medical Devices Directive. FibroScan® is indicated for the non invasive measurement of liver stiffness (E) and controlled attenuation parameter (CAP) in humans. It is expressly recommended to carefully read the guidance within the users' guide and the labeling of the device. FibroScan® examinations must only be performed at the request of qualified physician and by operators certified by the manufacturer or its accredited local representative. The values obtained with FibroScan® must be interpreted by a physician experienced in dealing with liver disease, taking into account the complete medical record of the patient.

DISCLAIMER : Our products are subject to regulatory requirements that vary from country to country and therefore may not be available for sale or distribution in all markets. This video is not intended for US audience : http://www.echosens.us/ .

Loading...


to add this to Watch Later

Add to

Loading playlists...